Principal Financial Group’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,962
| Closed | -$35K | – | 2521 |
|
|
2022
Q1 | $35K | Buy |
2,962
+65
| +2% | +$768 | ﹤0.01% | 2499 |
|
|
2021
Q4 | $47K | Sell |
2,897
-23,120
| -89% | -$375K | ﹤0.01% | 2484 |
|
|
2021
Q3 | $413K | Buy |
26,017
+282
| +1% | +$4.48K | ﹤0.01% | 2225 |
|
|
2021
Q2 | $2.38M | Buy |
+25,735
| New | +$2.38M | ﹤0.01% | 1866 |
|
|
2015
Q2 | – | Sell |
-4,925
| Closed | -$878K | – | 2179 |
|
|
2015
Q1 | $878K | Buy |
4,925
+45
| +0.9% | +$8.02K | ﹤0.01% | 1785 |
|
|
2014
Q4 | $1.16M | Buy |
4,880
+115
| +2% | +$27.3K | ﹤0.01% | 1778 |
|
|
2014
Q3 | $1.06M | Hold |
4,765
| – | – | ﹤0.01% | 1754 |
|
|
2014
Q2 | $1.26M | Hold |
4,765
| – | – | ﹤0.01% | 1761 |
|
|
2014
Q1 | $1.55M | Buy |
+4,765
| New | +$1.55M | ﹤0.01% | 1707 |
|